Abstract Introduction: Ewing sarcoma (ES) is an aggressive pediatric bone and soft tissue cancer that is absolutely dependent on the EWS::FLI1 fusion transcription factor. Despite this dependency, ES tumors demonstrate substantial variability in EWS::FLI1 transcriptional activity both across tumors and within individual tumors. Here, we investigate the inter- and intra-tumoral heterogeneity of EWS::FLI1 and its functional importance. Methods: We established a highly optimized siRNA knockdown protocol for EWS::FLI1 in 6 preclinical ES cell line models to achieve equal levels of suppression and evaluate differences in induced and repressed transcriptional targets and DNA binding events of EWS::FLI1. In order to investigate underlying mechanisms driving resistance, we employed state-of-the-art techniques including Cleavage Under Target (CUT Part 1 (Regular Abstracts); 2026 Apr 17-22; San Diego, CA. Philadelphia (PA): AACR; Cancer Res 2026;86(7 Suppl):Abstract nr 635.
Building similarity graph...
Analyzing shared references across papers
Loading...
Rachael Hinshaw
Zachary P. Tolstyka
Susan M. Kitchen-Goosen
Cancer Research
University of Michigan
Children's Hospital of Philadelphia
Van Andel Institute
Building similarity graph...
Analyzing shared references across papers
Loading...
Hinshaw et al. (Fri,) studied this question.
www.synapsesocial.com/papers/69d1fde4a79560c99a0a43fa — DOI: https://doi.org/10.1158/1538-7445.am2026-635
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: